Consumer staples stocks help Wall St. pare some losses

Biotechnology and pharmaceutical stocks came under pressure after President-elect Donald Trump told the Washington Post that he would target drug companies over pricing and that he was ready to unveil a plan to replace Obamacare. Investors maybe concerned that Trump is "going after the Affordable Care Act and is burning a little political capital that might otherwise have been used for business friendly matters," said Art Hogan, chief market strategist of Wunderlich Equity Capital Markets in New